PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Higher thiazide doses shown to reduce kidney stone events

Higher thiazide doses shown to reduce kidney stone events
2024-08-22
(Press-News.org) Higher thiazide doses are associated with greater reductions in urine calcium, which in turn correlate with fewer symptomatic kidney stone events, according to a Vanderbilt University Medical Center (VUMC) study published in JAMA Network Open. 

 

Thiazide diuretics, commonly prescribed to prevent kidney stone recurrence, are drugs that act directly on the kidneys to promote diuresis (urine flow) by inhibiting the sodium/chloride cotransporter located in the distal convoluted tubule of a nephron (the functional unit of a kidney). Thiazides are also used as a common treatment for high blood pressure and to clear fluid from the body in conditions such as heart failure.

 

First author Ryan Hsi, MD, FACS, associate professor in the Department of Urology at VUMC, said the study data help explain the findings of the multicenter Hydrochlorothiazide for Kidney Stone Recurrence Prevention (NOSTONE) trial, which reported that hydrochlorothiazide did not reduce recurrence of kidney stone events. 

 

“In light of our research, the calcium reductions in that study were modest and likely insufficient to affect recurrence risk,” Hsi said.  

 

“What this means for patients is that thiazides remain an important option in the toolkit for preventing kidney stone recurrence. It may be beneficial to monitor calcium excretion while on thiazide therapy to adjust dose and diet to attain an adequate reduction in urine calcium.”

 

A total of 634 participants were studied, revealing significant associations between higher thiazide doses and urine calcium reductions greater than those achieved in the NOSTONE trial, where participants took different doses of hydrochlorothiazide. 

 

For next steps, the researchers are interested in understanding which subtypes of thiazides and their dosing work best, and how best to optimize medication adherence, since these therapies are often administered long term.

 

 

 

 

 

 

 

 

END


[Attachments] See images for this press release:
Higher thiazide doses shown to reduce kidney stone events Higher thiazide doses shown to reduce kidney stone events 2

ELSE PRESS RELEASES FROM THIS DATE:

Reading your biological age in your blood or saliva? It’s not as simple as that

Reading your biological age in your blood or saliva? It’s not as simple as that
2024-08-22
How old are you, really? Your chronological age is the number of years you have been alive. Your biological age is how old your cells are which scientists believe may better assess one’s age-related health and disease risk.  People biologically age at different rates, depending on genetic and environmental factors, so that a person’s chronological age does not necessarily match their biological age. In recent years, direct-to-consumer biological age tests have become increasingly accessible and popular as interest has increased ...

Pong prodigy: Hydrogel material shows unexpected learning abilities

2024-08-22
In a study published today (22 August) in Cell Reports Physical Science, a team led by Dr Yoshikatsu Hayashi demonstrated that a simple hydrogel - a type of soft, flexible material - can learn to play the simple 1970s computer game ‘Pong’. The hydrogel, interfaced with a computer simulation of the classic game via a custom-built multi-electrode array, showed improved performance over time.  Dr Hayashi, a biomedical engineer at the University of Reading’s School of Biological Sciences, said: "Our research shows that even very simple materials can exhibit complex, adaptive behaviours typically associated with living systems or sophisticated AI.   "This ...

AI can speed up drug development

AI can speed up drug development
2024-08-22
Artificial intelligence (AI) can help identify molecules that could serve as new drugs for mental health disorders. AI can be used to predict the three-dimensional structures of important receptors and thereby speed up the development of potential drugs. This is the result of a new study from Uppsala University published in Science Advances. In drug development, experimental methods are often used to determine the three-dimensional structures of target proteins and to understand how molecules bind to them. This information is needed to design drug molecules efficiently. However, the process to determine structures can be demanding, meaning this ...

Bilateral reference framework for high-resolution dichotomous image segmentation

Bilateral reference framework for high-resolution dichotomous image segmentation
2024-08-22
A research team has developed a computer vision technique that can perform dichotomous image segmentation, high-resolution salient object detection, and concealed object detection in the same framework. Their novel bilateral reference framework (BiRefNet) is able to capture tiny-pixel features and holds potential for a wide range of practical computer vision applications.   The work is published in the journal CAAI Artificial Intelligence Research on August 22.   In computer vision research, ...

The future of robotics: Brain-inspired technologies paving the way

The future of robotics: Brain-inspired technologies paving the way
2024-08-22
In the ever-evolving field of robotics, a groundbreaking approach has emerged, revolutionizing how robots perceive, navigate, and interact with their environments. This new frontier, known as brain-inspired navigation technology, integrates insights from neuroscience into robotics, offering enhanced capabilities and efficiency. Brain-inspired navigation technologies are not just a mere improvement over traditional methods; they represent a paradigm shift. By mimicking the neural mechanisms of animals, these technologies provide robots with the ability to navigate through complex and unknown terrains with unprecedented accuracy ...

IHME’s 2024 Roux Prize awarded to Community Health Impact Coalition CEO – recognized for contributions to improve population health

2024-08-22
On behalf of the Community Health Impact Coalition (CHIC), Dr. Madeleine Ballard, global health leader and CEO of CHIC, is the Institute for Health Metrics and Evaluation’s 2024 Roux Prize winner. The award recognizes Dr. Ballard’s work alongside thousands of community health workers (CHWs) to secure quality care for all, through evidence-based health systems benefiting millions of people across the world.  Half of the world's population lacks access to essential health services. Around the globe, CHWs have stepped up to address this critical gap and deliver care in a way that improves access, increases equity, and saves lives. Despite their ...

New detectable gravitational wave source from collapsing stars predicted from simulations

New detectable gravitational wave source from collapsing stars predicted from simulations
2024-08-22
The death of a massive, rapidly spinning star can shake the universe. And the resulting ripples — known as gravitational waves — could be felt by instruments on Earth, according to new research published August 22 in The Astrophysical Journal Letters. These new sources of gravitational waves just await discovery, the scientists behind the research predict. The gravitational waves emerge following the violent deaths of rapidly rotating stars 15 to 20 times the mass of the sun. Upon running ...

New study examines use of opioids for chronic cough

2024-08-22
INDIANAPOLIS – Chronic cough, with symptoms lasting more than eight weeks, affects approximately one in 10 adults. Cough is among the most common reasons for seeking medical care in the United States, yet chronic cough is difficult to treat. One of the largest studies of chronic cough and one of the first to explore the use of opioids, which are known to suppress cough, to treat these patients, has found that 20 percent of patients with chronic cough received a prescription for a cough suppressant containing an opioid. With the goals of estimating opioid prescription in the chronic cough population and of informing alternative treatment ...

SwRI develops novel methodology for measuring blood-brain barrier permeability

SwRI develops novel methodology for measuring blood-brain barrier permeability
2024-08-22
SAN ANTONIO — August 22, 2024 —Scientists at Southwest Research Institute have developed a new screening method to identify drug formulations that can penetrate the blood-brain barrier (BBB), to facilitate treatment of brain diseases and conditions. “The BBB protects the brain and central nervous system from potentially harmful substances in the bloodstream, regulating the transport of essential nutrients and ions while maintaining the stability of the central nervous system,” said Research Engineer Nicholas McMahon, from SwRI’s Bioengineering group. “However, the very characteristics that make the BBB such an ...

Role of bitter polyphenols in the regulation of blood sugar

Role of bitter polyphenols in the regulation of blood sugar
2024-08-22
Bioactive compounds like polyphenols and their health benefits have long captured public attention and interest. Commonly present in plant-based food like fruits, vegetables, seeds, coffee, and tea, the polyphenols have a strong bitter taste and, in the normal course, is excreted by our body due to poor absorption. The polyphenols interact with human bitter taste receptors also known as Type 2 taste receptors (T2R) expressed within and outside the oral cavity. Notably, the activation of T2R expressed along the ...

LAST 30 PRESS RELEASES:

$3.5M grant to Georgia State will fuel space research across the globe

Polar molecules dance to the tunes of microwaves

Quantum researchers cause controlled ‘wobble’ in the nucleus of a single atom

Foods with low Nutri-Scores associated with an increased risk of cardiovascular diseases

Research reveals reality of Ice Age teen puberty

Use of biomarkers in the management of inflammatory bowel disease

Powered by renewable energy, microbes turn CO2 into protein and vitamins

Scientists aim to decode the genetic roots of mental illness on a large scale

Retinopathy associated with hair dye

Race, social determinants of health, and the quality of diabetic eye care

Molecular, socioeconomic, and clinical factors affecting racial and ethnic disparities in colorectal cancer survival

City of Hope and Biopharmaceutical Research Company announce first patient has received BRC-001, a first-in-class cannabinoid therapeutic, in a clinical trial investigating supportive care in breast c

Catalyzing environmental cleanup: A highly active and selective molecular catalyst and electrified membrane

Dual-feedback healing mechanism redefining anti-oxidation coatings in fiber reinforced composites

NCCN commits to sharing award-winning resources for people with cancer in Spanish and other languages

Development strategies for using carbon-based catalysts in CO2 conversion

Breakthrough research extends hope for gastric cancer patients with peritoneal metasis

Genetic carriers for sickle cell disease have higher risks of blood clots across diverse ancestries

Study finds unique pattern of blood clots in sickle cell trait, but low overall clot risk

Deep learning for strain field customization in bioreactor with dielectric elastomer actuator array

Killer yeasts may help remedy a craft beer brewing bother

Nationwide awards recognize 21 students, schools and educators’ commitment to health

Bake, melt or ignite: How synthesis methods have a profound impact on disordered materials

A majority of Americans can’t recall most First Amendment rights

2024 Blavatnik National Awards for Young Scientists announced

TTUHSC’s Jerry H. Hodge School of Pharmacy establishes Brain Drug Discovery Center

Collaborative three-campus QB3 research team awarded $12 million CIRM grant to study origins of autism in diverse population

Cannabis and older adults: Poll shows current use patterns, beliefs and risks

Dr. Baptiste Lacoste, of the Ottawa Hospital Research Institute and uOttawa Brain and Mind Research Institute, receives a SynGAP Research Fund (SRF) Grant for Groundbreaking Research on Vascular and M

$75,000 prize inspired by 18th century Scots economist attracts global entries

[Press-News.org] Higher thiazide doses shown to reduce kidney stone events